Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus

Tissue Antigens

Volumn 63, Issue 1, 2004, Pages 54-57

  Sanchez E ^a   Orozco, G ^a   Lopez Nevot M A ^b   Jimenez Alonso J ^b   Martin J ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Polymorphisms; Rheumatoid arthritis; Systemic lupus erythematosus; TLR2; TLR4

Indexed keywords

ARGININE; ASPARTIC ACID; GLUTAMINE; GLYCINE; ISOLEUCINE; THREONINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRYPTOPHAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ALLELES; ARTHRITIS, RHEUMATOID; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 1642521633     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2004.00162.x     Document Type: Article

References (23)

1. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001: 358: 903-11.
2. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001: 345: 340-50.
3. Imler JL, Hoffmann JA. Toll receptors in innate immunity. Trends Cell Biol 2001: 11: 304-11.
4. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003: 21: 335-76.
5. Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and grampositive bacterial cell wall components. Immunity 1999: 11: 443-51.
6. Shizuo A, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001: 2: 675-80.
7. Arbour N, Lorenz E, Schutte B et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000: 25: 187-91.
8. Lorenz E, Mira JP, Frees KL, Shwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002: 162: 1028-32.
9. Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphism and atherogenesis. N Engl J Med 2002: 347: 18-92.
10. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000: 68: 6398-401.
11. Kang TJ & Chae GU. Detection of toll-like receptor 2 mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001: 31: 53-8.
12. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification for systemic lupus erythematosus. Arthritis Rheum 1982: 25: 1271-7.
13. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988: 31: 315-24.
14. Lorenz E, Frees KL, Schwartz DA. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques 2001: 31: 22-4.
15. Schmitt C, Humeny A, Backer CM, Brune K, Pahl A. Polymorphism of TLR4 rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin Chem 2002: 48: 1661-70.
16. Reindl M, Lutterotti A, Ingram J et al. Mutations in the gene for toll-like receptor 4 and multiple sclerosis. Tissue Antigens 2003: 61: 85-8.
17. Okayama N, Fujimura K, Suehiro Y et al. Simple genotype analysis of the Asp299Gly polymorphism of the toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. J Clin Lab Anal 2002: 16: 56-58.
18. Schorder NWJ, Hermann C, Hamann L, Gobel UB, Hartung T, Schumann RR. High frequency of polymorphism Arg753Gln of the toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 2003: 81: 368-72.
19. Klinman D. Does activation of the innate immunity system contribute to the development of rheumatoid arthritis? Arthritis Rheum 2003: 48: 590-3.
20. Seibl R, Birchler T, Loeliger S et al. Expression and regulation of toll-like receptor 2 in rheumatoid arthritis. Am J Pathol 2003: 162: 1221-7.
21. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Sholmchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature 2002: 416: 603-7.
22. Agnese DM, Galvano JE, Hahm SJ et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002: 186: 1522-5.
23. Read RC, Pullin J, Gregory S et al. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 2001: 184: 640-2.